Gary R. MacVicar, MD works in the field of Oncology. He graduated from University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification". Gary R. MacVicar is a published physician. He has 2 papers published. The most current publication "A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma." Gary MacVicar accepts Medicare.
|
Dr. Arlene Dawravoo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rupa Chennamaneni, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stanley J. Borowicz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Lily P. Hussein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ann L. Mellott, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Laura Raftery, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter E. Friedell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stuart A. Krauss, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Elias I. Obeid, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Oana C. Danciu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Robert E. Molokie, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Raymond C. Bergan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Carmel Chou, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Selina L. Chow, MD
This Doctor is OpenDoctor Recommended.
|
|
Mohamed H. El Dinali
|